Literature DB >> 21293320

Infrared scanning laser ophthalmoscope imaging of the macula and its correlation with functional loss and structural changes in patients with stargardt disease.

Anastasios Anastasakis1, Gerald A Fishman, Martin Lindeman, Mohamed A Genead, Wensheng Zhou.   

Abstract

PURPOSE: To correlate the degree of functional loss with structural changes in patients with Stargardt disease.
METHODS: Eighteen eyes of 10 patients with Stargardt disease were studied. Scanning laser ophthalmoscope infrared images were compared with corresponding spectral-domain optical coherence tomography scans. Additionally, scanning laser ophthalmoscope microperimetry was performed, and results were superimposed on scanning laser ophthalmoscope infrared images and in selected cases on fundus autofluorescence images.
RESULTS: Seventeen of 18 eyes showed a distinct hyporeflective foveal and/or perifoveal area with distinct borders on scanning laser ophthalmoscope infrared images, which was less evident on funduscopy and incompletely depicted in fundus autofluorescence images. This hyporeflective zone corresponded to areas of significantly elevated psychophysical thresholds on microperimetry testing, in addition to thinning of the retinal pigment epithelium and disorganization or loss of the photoreceptor cell inner segment-outer segment junction and external-limiting membrane on spectral-domain optical coherence tomography.
CONCLUSION: Scanning laser ophthalmoscope infrared fundus images are useful for depicting retinal structural changes in patients with Stargardt disease. A spectral-domain optical coherence tomography/scanning laser ophthalmoscope microperimetry device allows for a direct correlation of structural abnormalities with functional defects that will likely be applicable for the determination of retinal areas for potential improvement of retinal function in these patients during future clinical trials and for the monitoring of the diseases' natural history.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21293320      PMCID: PMC3116073          DOI: 10.1097/IAE.0b013e3181f441f6

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  17 in total

1.  Analysis of retinal flecks in fundus flavimaculatus using optical coherence tomography.

Authors:  G Querques; N Leveziel; N Benhamou; M Voigt; G Soubrane; E H Souied
Journal:  Br J Ophthalmol       Date:  2006-06-05       Impact factor: 4.638

2.  Ultrahigh resolution optical coherence tomography in macular dystrophy.

Authors:  Matthias G Wirtitsch; Erdem Ergun; Boris Hermann; Angelika Unterhuber; Michael Stur; Christoph Scholda; Harald Sattmann; Tony H Ko; James G Fujimoto; Wolfgang Drexler
Journal:  Am J Ophthalmol       Date:  2005-12       Impact factor: 5.258

3.  Visualization of lipofuscin accumulation in Stargardt macular dystrophy by high-resolution Fourier-domain optical coherence tomography.

Authors:  Christina Gerth; Robert J Zawadzki; Stacey S Choi; John L Keltner; Susanna S Park; John S Werner
Journal:  Arch Ophthalmol       Date:  2007-04

4.  Infrared imaging of sub-retinal structures in the human ocular fundus.

Authors:  A E Elsner; S A Burns; J J Weiter; F C Delori
Journal:  Vision Res       Date:  1996-01       Impact factor: 1.886

5.  Clinical investigation of an infrared digital scanning laser ophthalmoscope.

Authors:  A Manivannan; J N Kirkpatrick; P F Sharp; J V Forrester
Journal:  Br J Ophthalmol       Date:  1994-02       Impact factor: 4.638

6.  Assessment of central visual function in Stargardt's disease/fundus flavimaculatus with ultrahigh-resolution optical coherence tomography.

Authors:  Erdem Ergun; Boris Hermann; Matthias Wirtitsch; Angelika Unterhuber; Tony H Ko; Harald Sattmann; Christoph Scholda; James G Fujimoto; Michael Stur; Wolfgang Drexler
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-01       Impact factor: 4.799

7.  Fundus autofluorescence in Stargardt macular dystrophy-fundus flavimaculatus.

Authors:  Noemi Lois; Anthony S Halfyard; Alan C Bird; Graham E Holder; Frederick W Fitzke
Journal:  Am J Ophthalmol       Date:  2004-07       Impact factor: 5.258

8.  Fundus flavimaculatus. A clinical classification.

Authors:  G A Fishman
Journal:  Arch Ophthalmol       Date:  1976-12

9.  A comparison of fundus autofluorescence and retinal structure in patients with Stargardt disease.

Authors:  Nuno L Gomes; Vivienne C Greenstein; Joshua N Carlson; Stephen H Tsang; R Theodore Smith; Ronald E Carr; Donald C Hood; Stanley Chang
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-03-25       Impact factor: 4.799

10.  Macular pigment and visual acuity in Stargardt macular dystrophy.

Authors:  Xinyuan Zhang; János Hargitai; Jaana Tammur; Amy Hutchinson; Rando Allikmets; Stanley Chang; Peter Gouras
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2002-09-14       Impact factor: 3.117

View more
  10 in total

1.  Transition zones between healthy and diseased retina in choroideremia (CHM) and Stargardt disease (STGD) as compared to retinitis pigmentosa (RP).

Authors:  Margot A Lazow; Donald C Hood; Rithambara Ramachandran; Tomas R Burke; Yi-Zhong Wang; Vivienne C Greenstein; David G Birch
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-12-20       Impact factor: 4.799

Review 2.  Multimodal fundus imaging in fundus albipunctatus with RDH5 mutation: a newly identified compound heterozygous mutation and review of the literature.

Authors:  Nan-Kai Wang; Lan-Hsin Chuang; Chi-Chun Lai; Chai Lin Chou; Hsueh-Yen Chu; Ling Yeung; Yen-Po Chen; Kuan-Jen Chen; Wei-Chi Wu; Tun-Lu Chen; An-Ning Chao; Yih-Shiou Hwang
Journal:  Doc Ophthalmol       Date:  2012-06-06       Impact factor: 2.379

3.  ELLIPSOID ZONE MAPPING AND OUTER RETINAL ASSESSMENT IN STARGARDT DISEASE.

Authors:  Sruthi Arepalli; Elias I Traboulsi; Justis P Ehlers
Journal:  Retina       Date:  2018-07       Impact factor: 4.256

4.  Abnormality in the external limiting membrane in early Stargardt disease.

Authors:  Tomas R Burke; Suzanne Yzer; Jana Zernant; R Theodore Smith; Stephen H Tsang; Rando Allikmets
Journal:  Ophthalmic Genet       Date:  2012-08-07       Impact factor: 1.803

5.  The value of retinal imaging with infrared scanning laser ophthalmoscopy in patients with stargardt disease.

Authors:  Robert Chun; Gerald A Fishman; Frederick T Collison; Edwin M Stone; Jana Zernant; Rando Allikmets
Journal:  Retina       Date:  2014-07       Impact factor: 4.256

6.  Inner and outer retinal changes in retinal degenerations associated with ABCA4 mutations.

Authors:  Wei Chieh Huang; Artur V Cideciyan; Alejandro J Roman; Alexander Sumaroka; Rebecca Sheplock; Sharon B Schwartz; Edwin M Stone; Samuel G Jacobson
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-03-20       Impact factor: 4.799

7.  The noninvasive retro-mode imaging modality of confocal scanning laser ophthalmoscopy in polypoidal choroidal vasculopathy: a preliminary application.

Authors:  Renpan Zeng; Xiongze Zhang; Yu Su; Meng Li; Kunfang Wu; Feng Wen
Journal:  PLoS One       Date:  2013-09-18       Impact factor: 3.240

8.  Highly sensitive measurements of disease progression in rare disorders: Developing and validating a multimodal model of retinal degeneration in Stargardt disease.

Authors:  Stanley Lambertus; Nathalie M Bax; Ana Fakin; Joannes M M Groenewoud; B Jeroen Klevering; Anthony T Moore; Michel Michaelides; Andrew R Webster; Gert Jan van der Wilt; Carel B Hoyng
Journal:  PLoS One       Date:  2017-03-29       Impact factor: 3.240

Review 9.  The role of multimodal imaging and vision function testing in ABCA4-related retinopathies and their relevance to future therapeutic interventions.

Authors:  Saoud Al-Khuzaei; Mital Shah; Charlotte R Foster; Jing Yu; Suzanne Broadgate; Stephanie Halford; Susan M Downes
Journal:  Ther Adv Ophthalmol       Date:  2021-12-19

10.  Perifoveal Cone- and Rod-Mediated Temporal Contrast Sensitivities in Stargardt Disease/Fundus Flavimaculatus.

Authors:  Julien Fars; Francesca Pasutto; Jan Kremers; Cord Huchzermeyer
Journal:  Invest Ophthalmol Vis Sci       Date:  2021-11-01       Impact factor: 4.799

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.